Profusa, Inc. income statement PFSA

It recorded a net loss of $35.8 million. Diluted earnings per share were -$107.01.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
Revenue
—
0
—
—
Research and development
3
—
—
—
Selling, general and administrative
25
—
—
—
Operating income
-28
-515.7%
-4
-198.3%
-2
-18.7%
-1
Pretax income
—
-9
-633.2%
2
-78.9%
8
Income tax
—
0
-82.4%
0
-8.5%
0
Net income
-36
-288.1%
-9
-894.4%
1
-83.8%
7
Basic EPS
-107.01
+70.0%
-357.14
-297716.7%
0.12
-60.0%
0.30
Diluted EPS
-107.01
+70.0%
-357.14
-297716.7%
0.12
-60.0%
0.30
Weighted average shares, basic
0
+1195.3%
0
-99.5%
5
+0.0%
5
Weighted average shares, diluted
0
+1195.3%
0
-99.5%
5
+0.0%
5
Other measures
Interest coverage
-10.99x
—
—
—
Margins
Operating margin
—
-4,500.00%
—
—
Pretax margin
—
-8,631.11%
—
—
Profit margin
—
-9,230.00%
—
—
Effective tax rate
—
—
28.22%
6.51%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
PFSA (Nasdaq), NVACW (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
, Emerging growth company
SEC CIK
1859807
Former names
NorthView Acquisition Corp (until Jul 15, 2025)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.